First-in-Man, Dose-escalation Trial of c-Met Kinase Inhibitor EMD 1204831 in Subjects With Advanced Solid Tumors
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
EMD Serono has closed enrollment into this trial prior to determination of maximum tolerated
dose (MTD). EMD Serono has decided not to pursue the development of EMD 1204831 in patients
with advanced solid tumors for reasons other than safety.